Sanger sequencing in routine KRAS testing: A review of 1720 cases from a pathologist's perspective

Umberto Malapelle, Claudio Bellevicine, Maria Salatiello, Caterina De Luca, Elisabetta Rispo, Palmira Riccio, Lucianna Sparano, Alfonso De Stefano, Chiara Carlomagno, Francesco Maria Maiello, Giulia Vita, Oscar Nappi, Giancarlo Troncone

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Sanger sequencing (SS) of PCR products is still the most frequent method to test colorectal cancer for KRAS mutations in routine practice. Methods: An audit of SS on 1720 routine cases was carried out, taking into account age, gender, specimen type (resection vs biopsies), tumour site ( primary vs metastasis), tumour stage, neoplastic cells abundance (>30% vs

Original languageEnglish
Pages (from-to)940-944
Number of pages5
JournalJournal of Clinical Pathology
Volume65
Issue number10
DOIs
Publication statusPublished - Oct 2012

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Sanger sequencing in routine KRAS testing: A review of 1720 cases from a pathologist's perspective'. Together they form a unique fingerprint.

Cite this